Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares shot up 2.8% during mid-day trading on Monday . The stock traded as high as $1.81 and last traded at $1.81. 500 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 3,694 shares. The stock had previously closed at $1.76.
Mayne Pharma Group Stock Performance
The business has a 50 day moving average of $1.74 and a 200-day moving average of $2.19.
Mayne Pharma Group Company Profile
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
See Also
- Five stocks we like better than Mayne Pharma Group
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
